SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-034081
Filing Date
2019-06-03
Accepted
2019-06-03 19:35:28
Documents
2
Period of Report
2019-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
2 POA DOCUMENT poa.txt EX-24.3_857116 3238
  Complete submission text file 0001209191-19-034081.txt   6337
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7707 GATEWAY BOULEVARD, SUITE 140 NEWARK CA 94560
Business Address
Kalkofen Donald A. (Reporting) CIK: 0001771066 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37852 | Film No.: 19874963